Adverse hematopoietic autologous transplantation. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy16

Hematopoietic Stem Cells Bone Marrow Cells, Cultured Bone Marrow Cells Stem Cells T-Lymphocytes Transplants Antilymphocyte Serum T-Lymphocytes, Cytotoxic Liver Lymphocytes Dendritic Cells Portal Vein Mesenchymal Stromal Cells Fetal Blood CD4-Positive T-Lymphocytes

Organisms7

Transplantation Chimera Lentivirus Rabbits Mice, Inbred C57BL Rats, Inbred Lew Mice, SCID Mice, Inbred BALB C

Diseases38

Multiple Myeloma Lymphoma, Non-Hodgkin Recurrence Graft vs Host Disease Hodgkin Disease Hematologic Neoplasms Neoplasm, Residual Lymphoma Leukemia Leukemia, Myeloid, Acute Myelodysplastic Syndromes Liver Failure Postoperative Complications Neoplasm Recurrence, Local Disease Progression Cadaver Liver Diseases Acute Disease Kidney Failure, Chronic Anemia, Aplastic Cytomegalovirus Infections Bronchiolitis Obliterans Blood Group Incompatibility Precursor Cell Lymphoblastic Leukemia-Lymphoma Disease Models, Animal End Stage Liver Disease Infection Leukemia, Myeloid Hematologic Diseases Brain Death Hepatic Veno-Occlusive Disease Liver Failure, Acute Liver Cirrhosis Lymphoproliferative Disorders Leukemia, Myelogenous, Chronic, BCR-ABL Positive Primary Graft Dysfunction Delayed Graft Function Liver Neoplasms

Chemicals and Drugs34

Melphalan Antigens, CD34 Carmustine Granulocyte Colony-Stimulating Factor Cyclophosphamide Etoposide Busulfan Immunosuppressive Agents Cytarabine Myeloablative Agonists Thalidomide Kanamycin Kinase Vincristine Idarubicin Prednisone Antineoplastic Agents, Alkylating Dexamethasone Antibodies, Monoclonal, Murine-Derived Doxorubicin Antibodies, Monoclonal Antineoplastic Agents Antigens, CD Cyclosporine Tacrolimus HLA Antigens Recombinant Proteins Antilymphocyte Serum Thiotepa Mycophenolic Acid Antigens, Neoplasm ABO Blood-Group System Vidarabine Isoantibodies Isoantigens

Analytical, Diagnostic and Therapeutic Techniques and Equipment86

Transplantation, Autologous Hematopoietic Stem Cell Transplantation Transplantation, Homologous Bone Marrow Transplantation Liver Transplantation Transplantation Conditioning Stem Cell Transplantation Kidney Transplantation Hematopoietic Stem Cell Mobilization Peripheral Blood Stem Cell Transplantation Treatment Outcome Combined Modality Therapy Cell Transplantation Heart Transplantation Salvage Therapy Lung Transplantation Bone Marrow Purging Leukapheresis Whole-Body Irradiation Antineoplastic Combined Chemotherapy Protocols Remission Induction Organ Transplantation Disease-Free Survival Survival Analysis Retrospective Studies Blood Transfusion, Autologous Survival Rate Pancreas Transplantation Islets of Langerhans Transplantation Transplantation Follow-Up Studies Transplantation, Isogeneic Blood Component Removal Feasibility Studies Prognosis Transplantation, Heterotopic Cord Blood Stem Cell Transplantation Genetic Therapy Cell Separation Heart-Lung Transplantation Colony-Forming Units Assay Immunomagnetic Separation Blood Cell Count Cell Culture Techniques Immunosuppression Prospective Studies Transduction, Genetic Histocompatibility Testing Skin Transplantation Fetal Tissue Transplantation Mesenchymal Stem Cell Transplantation Flow Cytometry Transplantation, Heterologous Tissue Transplantation Multivariate Analysis Corneal Transplantation Brain Tissue Transplantation Polymerase Chain Reaction Facial Transplantation Organ Preservation Donor Selection Lymphocyte Culture Test, Mixed Risk Factors Tissue and Organ Harvesting Lymphocyte Activation Postoperative Period Actuarial Analysis Lymphocyte Transfusion Hand Transplantation Patient Selection Neoplasm Transplantation Lymphocyte Depletion Disease Models, Animal Bone Transplantation Immunotherapy, Adoptive Biopsy Models, Animal Fatal Outcome Blood Transfusion Anastomosis, Surgical Immunotherapy Immunophenotyping Kaplan-Meier Estimate Incidence Cryopreservation Postoperative Care

Phenomena and Processes18

Graft Survival Graft Rejection Time Factors Transplantation Immunology Graft vs Tumor Effect Hematopoiesis Blood Cell Count Transplantation Tolerance Genetic Vectors Transduction, Genetic Cell Differentiation Histocompatibility Cytotoxicity, Immunologic Lymphocyte Activation Chimerism Graft vs Leukemia Effect Immune Tolerance Regeneration

Information Science3

Survival Rate Fatal Outcome Incidence

Named Groups2

Tissue Donors Living Donors

Health Care20

Treatment Outcome Disease-Free Survival Survival Analysis Retrospective Studies Survival Rate Follow-Up Studies Feasibility Studies Tissue and Organ Procurement Prospective Studies Multivariate Analysis Waiting Lists Donor Selection Risk Factors Postoperative Period Actuarial Analysis Patient Selection Fatal Outcome Kaplan-Meier Estimate Incidence Postoperative Care

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Information Science Named Groups Health Care

Transplantation, Autologous Hematopoietic Stem Cell Transplantation Transplantation, Homologous Bone Marrow Transplantation Liver Transplantation Transplantation Conditioning Stem Cell Transplantation Multiple Myeloma Kidney Transplantation Melphalan Hematopoietic Stem Cell Mobilization Graft Survival Peripheral Blood Stem Cell Transplantation Treatment Outcome Combined Modality Therapy Cell Transplantation Heart Transplantation Lymphoma, Non-Hodgkin Salvage Therapy Antigens, CD34 Lung Transplantation Bone Marrow Purging Carmustine Recurrence Leukapheresis Graft vs Host Disease Granulocyte Colony-Stimulating Factor Cyclophosphamide Whole-Body Irradiation Antineoplastic Combined Chemotherapy Protocols Remission Induction Hematopoietic Stem Cells Organ Transplantation Disease-Free Survival Survival Analysis Etoposide Busulfan Retrospective Studies Hodgkin Disease Blood Transfusion, Autologous Hematologic Neoplasms Graft Rejection Immunosuppressive Agents Survival Rate Pancreas Transplantation Cytarabine Islets of Langerhans Transplantation Tissue Donors Time Factors Transplantation Immunology Transplantation Follow-Up Studies Graft vs Tumor Effect Myeloablative Agonists Transplantation Chimera Thalidomide Kanamycin Kinase Bone Marrow Transplantation, Isogeneic Vincristine Blood Component Removal Feasibility Studies Prognosis Neoplasm, Residual Lymphoma Hematopoiesis Living Donors Cells, Cultured Transplantation, Heterotopic Cord Blood Stem Cell Transplantation Genetic Therapy Cell Separation Idarubicin Prednisone Bone Marrow Cells Heart-Lung Transplantation Leukemia Antineoplastic Agents, Alkylating Dexamethasone Leukemia, Myeloid, Acute Myelodysplastic Syndromes Colony-Forming Units Assay Stem Cells Immunomagnetic Separation Blood Cell Count Cell Culture Techniques Immunosuppression Transplantation Tolerance Genetic Vectors Tissue and Organ Procurement Prospective Studies Transduction, Genetic Antibodies, Monoclonal, Murine-Derived Lentivirus Histocompatibility Testing Doxorubicin Antibodies, Monoclonal Skin Transplantation Liver Failure Fetal Tissue Transplantation

No FAQ available that match "adverse hematopoietic autologous transplantation"